CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 6.3% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics AG (CRSP) is a biotechnology company focused on developing transformative gene-based medicines for patients with serious diseases. The company is known for its innovative CRISPR technology that allows for precise genetic editing.

Why is CRISPR Therapeutics AG going up?

CRSP stock is up 6.3% on Apr 11, 2025 13:46

• Despite a slight dip in the stock price, CRSP had a strong bullish movement overall for the day.
• Cathie Wood's Ark Invest loading up on CRSP shares could have contributed to the bullish momentum, signaling confidence in the company's future prospects.
• The market might be reacting positively to the potential of CRISPR Therapeutics AG's gene-editing technology in developing groundbreaking treatments, driving investor optimism and pushing the stock price higher.
• Overall, the bullish movement in CRSP could be attributed to both positive market sentiment towards the biotech sector and specific investor interest in the company's innovative approach to genetic medicine.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics AG ( CRSP ) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $34.26, moving -1.81% from the previous trading session.

https://www.zacks.com/stock/news/2444918/crispr-therapeutics-ag-crsp-stock-moves--181-what-you-should-know

Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox - ARK Fintech Innovation ETF ( BATS:ARKF ) , Amazon.com ( NASDAQ:AMZN )

On Friday, April 4, 2025, Cathie Wood-led Ark Invest made substantial trades involving several prominent companies including Coinbase Global Inc. COIN, Amazon.com Inc. AMZN, CRISPR Therapeutics AG CRSP, Beam Therapeutics Inc. BEAM, UiPath Inc. PATH, Roblox Corp. RBLX, MercadoLibre Inc.

https://www.benzinga.com/25/04/44655592/cathie-woods-ark-invest-loads-up-on-amazon-coinbase-offloads-uipath-roblox

CRISPR Therapeutics AG ( CRSP ) Stock Moves -0.03%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $32.65 in the latest trading session, marking a -0.03% move from the prior day.

https://www.zacks.com/stock/news/2440859/crispr-therapeutics-ag-crsp-stock-moves--003-what-you-should-know

Trending Today

Curve DAO Token ($CRV) Crypto Forecast: Down 5.4% Today

Memecoin ($MEME) Crypto Forecast: Up 5.7% Today

Decentraland ($MANA) Crypto Forecast: Up 5.4% Today

Wormhole ($W) Crypto Forecast: Up 5.2% Today

Celestia ($TIA) Crypto Forecast: Up 5.0% Today

MANTRA ($OM) Crypto Forecast: Down 6.9% Today

JasmyCoin ($JASMY) Crypto Forecast: Down 6.9% Today

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 22.4% Today

Snap-On Incorporated ($SNA) Stock Forecast: Down 7.1% Today

Devon Energy Corporation ($DVN) Stock Forecast: Up 5.0% Today

CRISPR Therapeutics AG Price History

03.11.2024 - CRSP Stock was down 5.1%

• Analysts project a potential upside of 58.3% for CRSP.
• Earnings estimate revisions show a positive trend, hinting at potential future stock growth.
• Despite optimistic analyst outlook, CRSP's stock witnessed a bearish movement today, signaling a discrepancy between predictions and market performance.

22.00.2025 - CRSP Stock was up 7.1%

• Recent significant trades involving CRISPR Therapeutics AG by a well-known investment firm could have sparked investor optimism and confidence in the company's future prospects.
• The recent uptrend in CRSP's stock price may be a result of heightened attention from both individual and institutional investors following the mentioned investment firm's positions in the company.
• Continued interest from the investment firm in CRSP suggests a strong belief in the potential of CRISPR gene-editing technology, contributing to positive sentiment and driving the stock price up.
• The market's response indicates that investors perceive CRSP as a significant player in the biotech industry with promising growth opportunities, resulting in increased buying interest and a rise in the stock price.

06.00.2025 - CRSP Stock was up 4.4%

• CRSP stock demonstrated a robust bullish trend, rising by +1.84% despite overall market conditions.
• The upsurge in CRSP stock could be linked to favorable developments in the company's CRISPR technology.
• Investors may be hopeful about CRSP's future possibilities, prompting heightened buying interest.
• CRSP's steady performance amidst market fluctuations may suggest high investor trust in the company's innovative gene-based therapies approach.

08.00.2025 - CRSP Stock was down 5.3%

• Key factors contributing to the bearish movement in CRSP stock include:
• Closing at $41.92, reflecting a -1.2% decrease from the prior trading session.
• Negative market sentiment influencing the stock more than the overall market.
• Potential profit-taking by investors following a recent price surge.
• Uncertainty surrounding regulatory approvals for CRISPR-based therapies impacting investor confidence.

05.01.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) exhibited strong bullish movement today, surpassing the overall stock market performance.
• Investor confidence in CRISPR Therapeutics AG (CRSP) might have been bolstered by Cathie Wood's Ark Invest's positioning, influencing the positive stock movement.
• The company's emphasis on innovative gene-based therapies could have contributed to the optimistic investor sentiment.
• The bullish movement in CRSP stock today may be attributed to the favorable market sentiment, strategic investments by influential entities like Ark Invest, and the promising future of CRISPR technology.

11.10.2024 - CRSP Stock was up 6.2%

• Analysts are optimistic about CRISPR Therapeutics, with a mean price target suggesting a significant upside potential of 62.8% in the stock.
• Despite mixed third-quarter results, including a narrower loss than expected and sales missing estimates, the progress in the commercial launch of Casgevy, the first CRISPR-based gene therapy, is a positive indicator for the company's future growth prospects.
• The bullish movement in CRSP today could be attributed to the overall positive sentiment from analysts regarding the company's potential and the advancements in its groundbreaking gene-editing technology.

07.03.2025 - CRSP Stock was up 5.1%

• Recent significant trades involving CRISPR Therapeutics AG (CRSP) by Ark Invest could have influenced investor confidence in the stock.
• An upcoming presentation at the 24th Annual Needham Virtual Healthcare Conference may have sparked positive anticipation and interest in the company's future.
• Favorable market sentiment toward innovative biopharmaceutical firms like CRISPR Therapeutics AG likely played a role in the stock's bullish movement, especially given ongoing advancements in gene-based medicine research.

26.02.2025 - CRSP Stock was down 5.4%

• Despite closing slightly higher in one session, the overall trend for CRSP has been negative, with a notable decline of -1.84%.
• The bearish movement could be attributed to profit-taking by investors after a period of growth or concerns about the company's pipeline or financial performance.
• It's important for investors to monitor any upcoming developments or announcements from CRISPR Therapeutics AG that could potentially reverse the current downward trend.

23.00.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics (CRSP) experienced a strong bullish movement today, with shares surging by 6.5%.
• The increased trading volume and positive trend in earnings estimate revisions contributed to the stock's upward momentum.
• Significant trades involving CRSP by an influential investment firm could have also fueled investor optimism and buying interest in the stock.
• The market seems to be reacting positively to the company's recent developments and the overall bullish sentiment in the biotech sector.

11.03.2025 - CRSP Stock was up 6.3%

• Despite a slight dip in the stock price, CRSP had a strong bullish movement overall for the day.
• Cathie Wood's Ark Invest loading up on CRSP shares could have contributed to the bullish momentum, signaling confidence in the company's future prospects.
• The market might be reacting positively to the potential of CRISPR Therapeutics AG's gene-editing technology in developing groundbreaking treatments, driving investor optimism and pushing the stock price higher.
• Overall, the bullish movement in CRSP could be attributed to both positive market sentiment towards the biotech sector and specific investor interest in the company's innovative approach to genetic medicine.

14.01.2025 - CRSP Stock was up 16.6%

• The bullish movement in CRSP stock today is linked to positive Q4 earnings and revenue surpassing estimates, indicating strong financial performance and market confidence in the company's innovative gene therapy solutions.
• An analyst upgrade from Telsey Advisory Group may have also contributed to the positive sentiment, showing increased optimism and potential future growth prospects for CRISPR Therapeutics.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, further strengthens investor confidence in CRSP's technological advancements and market potential, leading to an increase in the stock price.

12.01.2025 - CRSP Stock was up 8.1%

• Strong Q4 earnings and revenues were reported by CRSP, surpassing estimates.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, contributed to the bullish movement.
• Investor confidence in CRSP's innovative gene therapy solutions likely drove the stock price higher.